Omada Health (NASDAQ:OMDA) President Sells $90,618.34 in Stock

Omada Health, Inc. (NASDAQ:OMDA) President Wei-Li Shao sold 5,618 shares of the stock in a transaction on Monday, December 29th. The stock was sold at an average price of $16.13, for a total value of $90,618.34. Following the completion of the sale, the president owned 69,079 shares of the company’s stock, valued at $1,114,244.27. The trade was a 7.52% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Omada Health Price Performance

Shares of Omada Health stock traded down $0.79 during trading hours on Tuesday, hitting $15.34. The company’s stock had a trading volume of 881,173 shares, compared to its average volume of 683,957. The business has a 50 day moving average price of $19.35 and a two-hundred day moving average price of $20.09. Omada Health, Inc. has a 12-month low of $14.14 and a 12-month high of $28.40.

Analysts Set New Price Targets

Several research firms have recently issued reports on OMDA. Evercore ISI lifted their price objective on shares of Omada Health from $27.00 to $28.00 and gave the company an “outperform” rating in a research report on Friday, November 7th. Barclays raised their price objective on Omada Health from $28.00 to $29.00 and gave the company an “overweight” rating in a research note on Friday, November 7th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Omada Health in a research note on Wednesday, October 8th. Morgan Stanley set a $32.00 price objective on shares of Omada Health in a research note on Thursday, December 18th. Finally, Needham & Company LLC increased their price target on Omada Health from $26.00 to $28.00 and gave the stock a “buy” rating in a report on Friday, November 7th. Eight research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Omada Health currently has a consensus rating of “Moderate Buy” and an average target price of $27.11.

Institutional Investors Weigh In On Omada Health

Institutional investors and hedge funds have recently bought and sold shares of the company. Raymond James Financial Inc. bought a new position in shares of Omada Health during the 2nd quarter worth $32,000. Strs Ohio purchased a new position in shares of Omada Health in the 3rd quarter valued at $38,000. Rakuten Investment Management Inc. bought a new stake in Omada Health during the third quarter valued at about $49,000. JPMorgan Chase & Co. purchased a new position in Omada Health in the third quarter valued at about $82,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in Omada Health in the third quarter worth about $95,000.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.